Research shows that higher levels of a vitamin K-deficiency marker called dp-ucMGP predict faster hardening of heart valves, while a protective protein called fetuin-A slows this process. In a Gram Research analysis of 6,547 adults tracked for 9.4 years, those with elevated dp-ucMGP accumulated calcium in their aortic valve 0.94 Agatston units faster per year and in their mitral annulus 3.9 units faster per year, suggesting vitamin K supplementation might prevent valve calcification.

Researchers tracked over 6,500 adults for nearly a decade to understand why heart valves harden and thicken with age. They found that three specific proteins in the blood can predict whether someone’s heart valves will calcify, a condition that can eventually restrict blood flow. According to Gram Research analysis, vitamin K deficiency appears to be a key player, suggesting that targeted supplementation might help prevent this common heart problem in older adults.

Key Statistics

A 2026 study of 6,547 adults published in the Journal of the American Heart Association found that higher levels of dp-ucMGP, a marker of vitamin K deficiency, predicted 0.94 additional Agatston units of aortic valve calcification per year and 3.9 units of mitral annulus calcification per year.

According to research reviewed by Gram, fetuin-A, a blood protein that keeps calcium dissolved, showed a protective effect by slowing aortic valve calcification by 0.89 Agatston units per year for each standard increase in levels.

A 9.4-year follow-up study of 6,547 multiethnic adults found that FGF-23, a hormone regulating mineral balance, was associated with 2.61 additional Agatston units of mitral annulus calcification per year.

The MESA study demonstrated that vitamin K status, measured through blood markers, independently predicted heart valve calcification progression in a diverse population, suggesting vitamin K supplementation warrants clinical trial testing.

The Quick Take

  • What they studied: Whether three specific blood proteins can predict if someone’s heart valves will harden and calcify over time
  • Who participated: 6,547 adults from different ethnic backgrounds who were tracked for about 9.4 years as part of a large heart health study
  • Key finding: Two blood markers linked to vitamin K deficiency predicted faster valve hardening, while a third marker that helps dissolve calcium actually protected against it
  • What it means for you: Blood tests measuring these three proteins might help doctors identify who is at highest risk for valve calcification early on, potentially opening the door to vitamin K supplementation as a preventive treatment

The Research Details

This was a long-term observational study, meaning researchers followed the same people over time and measured changes without giving them any specific treatment. The team measured three blood proteins at the start of the study: dp-ucMGP (a form of vitamin K-dependent protein), FGF-23 (a hormone that affects mineral balance), and fetuin-A (a protein that helps keep calcium dissolved in blood). They then used CT scans to measure calcium buildup in heart valves at multiple time points over nearly a decade. The researchers used statistical models to see which blood markers predicted faster calcium accumulation in the aortic valve (the main valve leaving the heart) and the mitral annulus (the ring of tissue around another heart valve).

Understanding what causes heart valves to calcify is important because this process affects millions of older adults and can eventually require surgery. By identifying blood markers that predict this problem, doctors could potentially catch it early and try preventive treatments before the valve becomes damaged. This approach is much better than waiting until someone has symptoms.

This study is strong because it followed a large, diverse group of people for many years with repeated measurements of valve calcification. The researchers carefully adjusted their analysis for other factors that might affect valve health, like age, blood pressure, and cholesterol. However, because this was an observational study, it can show associations but cannot prove that these blood markers directly cause valve calcification. The findings need to be tested in clinical trials where some people receive vitamin K supplementation and others receive a placebo.

What the Results Show

Higher levels of dp-ucMGP, a marker of vitamin K deficiency, were strongly associated with faster calcification of both the aortic valve and the mitral annulus. For every standard increase in dp-ucMGP levels, the aortic valve accumulated calcium about 0.94 Agatston units per year faster, and the mitral annulus accumulated calcium about 3.9 units per year faster. This suggests that vitamin K deficiency may be a modifiable risk factor for valve calcification. FGF-23, a hormone involved in mineral metabolism, was also associated with faster mitral annulus calcification at about 2.6 units per year for each standard increase. In contrast, fetuin-A, a protein that helps keep calcium dissolved in the bloodstream, showed a protective effect: higher levels were associated with slower aortic valve calcification, about 0.89 units per year slower.

The study found that the three blood markers had different effects on the two valve locations studied. While dp-ucMGP affected both valves, FGF-23 primarily influenced the mitral annulus, and fetuin-A showed its strongest protective effect on the aortic valve. This suggests that different biological mechanisms may drive calcification in different parts of the heart. The findings were consistent across the different ethnic groups in the study, indicating these associations are not limited to one population.

Previous research has suggested that vitamin K plays a role in preventing calcification, but this is one of the first large, long-term studies to directly measure vitamin K status through blood markers and track actual valve calcification over many years. The findings support earlier laboratory studies showing that vitamin K-dependent proteins help prevent calcium from depositing in tissues. The protective effect of fetuin-A aligns with previous research on this protein’s role in mineral metabolism.

This study cannot prove that vitamin K deficiency causes valve calcification, only that they are associated. The researchers could not measure actual vitamin K intake, only a marker of vitamin K status in the blood. Some participants were lost to follow-up over the 9-year period, which could affect results. The study was observational, so other unmeasured factors could explain the associations found. Finally, these findings need to be confirmed in clinical trials before doctors can recommend vitamin K supplementation specifically to prevent valve calcification.

The Bottom Line

Based on this research, doctors may eventually use blood tests measuring these three proteins to identify people at high risk for valve calcification. However, vitamin K supplementation is not yet recommended as a standard treatment for this condition. People with known valve disease should discuss their individual risk factors with their cardiologist. This research is strong enough to justify clinical trials testing whether vitamin K supplementation can slow valve calcification in high-risk individuals.

This research is most relevant to older adults, particularly those with family history of heart valve disease or those already diagnosed with early valve calcification. People with chronic kidney disease, which affects mineral metabolism, should also pay attention to these findings. Cardiologists and preventive medicine doctors should consider these findings when counseling patients about heart health. This is less immediately relevant to younger, healthy adults without known valve disease.

Valve calcification is a slow process that develops over years or decades. Even if vitamin K supplementation proves effective, benefits would likely take months to years to become apparent. This is not a quick fix but rather a potential long-term preventive strategy for people at high risk.

Frequently Asked Questions

What blood test can predict if my heart valves will calcify?

Researchers identified three blood markers that predict valve calcification: dp-ucMGP (vitamin K status), FGF-23 (mineral hormone), and fetuin-A (calcium-regulating protein). Currently, these tests are primarily research tools, but your doctor can discuss cardiovascular risk assessment.

Can vitamin K supplements prevent heart valve hardening?

This study suggests vitamin K deficiency is linked to valve calcification, but vitamin K supplementation is not yet proven to prevent it. Clinical trials are needed before doctors can recommend supplements for this purpose. Discuss with your cardiologist if you have valve concerns.

Who is most at risk for heart valve calcification?

Older adults, people with chronic kidney disease, those with high blood pressure or cholesterol, and individuals with family history of valve disease face higher risk. This study suggests people with vitamin K deficiency markers may be at particular risk.

How fast does heart valve calcification progress?

The study tracked calcification over 9.4 years, showing it’s a slow process. People with high vitamin K deficiency markers accumulated calcium about 0.94 to 3.9 units per year depending on which valve, but progression varies significantly between individuals.

Should I eat more vitamin K-rich foods to protect my heart valves?

Maintaining adequate vitamin K intake through foods like leafy greens, broccoli, and Brussels sprouts is generally healthy, but this study doesn’t yet prove it prevents valve calcification. Discuss personalized recommendations with your doctor, especially if you take blood thinners.

Want to Apply This Research?

  • Track vitamin K intake through food sources like leafy greens, broccoli, and Brussels sprouts. Log servings weekly and aim for consistent intake, as vitamin K status depends on regular consumption.
  • Add one vitamin K-rich food to your diet daily. Start with easy options like adding spinach to smoothies, kale to soups, or broccoli to dinner. Consistency matters more than quantity for maintaining stable vitamin K levels.
  • If you have risk factors for valve disease, ask your doctor about baseline blood work measuring these three markers. Set annual reminders to discuss cardiovascular health with your healthcare provider and track any new symptoms like heart murmurs or shortness of breath during activity.

This research identifies associations between blood markers and valve calcification but does not prove causation. Vitamin K supplementation is not currently recommended as a standard treatment for valve calcification. Anyone with known or suspected heart valve disease should consult with a cardiologist before making dietary changes or starting supplements. This article is for educational purposes and should not replace professional medical advice. Results from observational studies require confirmation through clinical trials before clinical recommendations can be made.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Regulators of Mineralization and Long-Term Progression of Aortic Valve and Mitral Annular Calcification: MESA. , Journal of the American Heart Association (2026). PubMed 42786596 | DOI
Topics
heart valve calcification vitamin K deficiency aortic valve disease mitral annulus calcification cardiovascular health blood biomarkers preventive cardiology aging heart health